Seasonal Influenza Vaccine Market in Asia-Pacific Region - Cell Culture Technology-Based Vaccines to Revolutionize the Market by Faster Production and High Initial Purity - GBI Research Reports

Seasonal Influenza Vaccine Market in Asia-Pacific Region - Cell Culture Technology-Based Vaccines to Revolutionize the Market by Faster Production and High Initial Purity

Seasonal Influenza Vaccine Market in Asia-Pacific Region - Cell Culture Technology-Based Vaccines to Revolutionize the Market by Faster Production and High Initial Purity - GBI Research Reports
Seasonal Influenza Vaccine Market in Asia-Pacific Region - Cell Culture Technology-Based Vaccines to Revolutionize the Market by Faster Production and High Initial Purity
Published Dec 14, 2011
156 pages — Published Dec 14, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider has released its latest research Seasonal Influenza Vaccine Market in Asia-Pacific Region Cell Culture Technology-Based Vaccines to Revolutionize the Market by Faster Production and High Initial Purity Description which essentially provides insights into the seasonal influenza vaccine sales forecasts for the Asia-Pacific Region until 2017. The report also delves deep into vaccination patterns for seasonal influenza in the Asia-Pacific Region. Further, the geographical distribution of seasonal influenza vaccines across Japan, Australia, New Zealand, China, Taiwan, Philippines, Hong Kong, Malaysia, India and Singapore are also provided in the report. The report offers a clear view of the regulatory landscape in the Asia-Pacific countries. The report also reveals the seasonal influenza vaccine R&D pipeline and offers profiles of promising vaccines. The report explores the competitive landscape including profiles for top companies. Finally, the key trend analysis on mergers and acquisitions, and licensing agreements involving seasonal influenza vaccines is also presented.

Treatment of seasonal influenza is dominated by two categories of treatment options, vaccines and antiviral therapies. In the recent years it was observed that demand for seasonal influenza vaccines have increased due to changed perception of patient population. The patient population is of the opinion that preventive healthcare is better compared to curative healthcare; this led to increased demand of vaccines in Asia-Pacific region. Asia-Pacific (APAC) region is an attractive market for seasonal influenza vaccine manufacturers. Major drivers in the market is increasing awareness, increasing vaccination coverage in the APAC countries and rising government support for immunization against seasonal influenza. Major restraints of the market are variable demand and limited production capacity. Traditional egg based manufacturing of seasonal influenza vaccines is being replaced with cell culture vaccines. Cell culture based production of vaccines is expected to reduce the problems associated with the production and use of seasonal influenza vaccines which will further increase the vaccination coverage in the APAC region.

GBI Research Analysis shows that the seasonal influenza vaccine market in the APAC Region is a fast growing market. This is due to increased vaccination coverage against seasonal influenza in the region. GBI Research forecasts the market to grow at double digit Compounded Annual Growth Rate (CAGR) of 8.9% during the period 2010-2017 from $1,154.9m in 2010 to $2,095.9m by 2017. This growth is driven by factors such as increasing awareness on influenza caused by threat of pandemic influenza, increasing vaccination coverage because of the governments support, growing population in the APAC region and entry of novel vaccines and production technologies.

GBI Research finds that the Philippines seasonal influenza vaccine market is the most attractive in the seasonal influenza vaccine market for Asia-Pacific region both in terms of value and growth rate. Other attractive markets in terms of growth rate are Malaysias and Singapores seasonal influenza vaccine markets. Australias seasonal influenza vaccine market is also a large sized attractive market forecast to grow at a healthy growth rate during the period 2010-2017. In-depth analysis of the report is based on propriety databases, primary and secondary research and in house analysis by the GBI Research team of experts.

GBI Research analysis shows that the R&D pipeline for the seasonal influenza vaccines is moderately strong with approximately 50% of the pipeline in the Phase II and Phase III. The major vaccine manufacturers are focused upon acquiring new technologies and strengthening their presence in the market by collaborating

  
Source:
Document ID
GBIHC177MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents410
  List of Tables83
  List of Figures113
Seasonal Influenza Vaccine Market in Asia-Pacific Region - Introduction142
  GBI Research Report Guidance151
Seasonal Influenza Vaccine Market in Asia-Pacific Region - Market Overview164
  Production Cycle for the Seasonal Influenza Vaccines161
  The Asia-Pacific Region Seasonal Influenza Vaccine Market161
  Revenue for the Seasonal Influenza Vaccine Market172
  Geographical Segmentation191
Seasonal Influenza Vaccine Market in Asia-Pacific Region - Geographical Landscape2080
  Australia201
    Vaccination Pattern201
      Population201
      Vaccinated Population Contribution212
      Vaccination Coverage231
      Number of Doses per Person231
      Number of Total Doses232
      Doses Contribution251
      Number of Public and Private Doses251
    Cost of Vaccine251
    Total Revenue262
  New Zealand281
    Vaccination Pattern281
      Population281
      Vaccinated Population Contribution292
      Vaccination Coverage311
      Number of Doses per Person311
      Number of Total Doses312
      Doses Contribution331
      Number of Public and Private Doses331
    Cost of Vaccine331
    Total Revenue342
    Major Players by Market Share361
  Taiwan371
    Vaccination Pattern371
      Population371
      Vaccinated Population Contribution381
      Vaccination Coverage391
      Number of Doses per Person391
      Number of Total Doses392
      Doses Contribution411
      Number of Public and Private Doses411
    Cost of Vaccine411
    Total Revenue422
    Major Players by Market Share441
  Philippines451
    Vaccination Pattern451
      Population451
      Vaccinated Population Contribution461
      Vaccination Coverage471
      Number of Doses per Person471
      Number of Total Doses472
      Doses Contribution491
      Number of Public and Private Doses491
    Cost of Vaccine491
    Total Revenue502
    Major Players by Market Share521
  Malaysia531
    Vaccination Pattern531
      Population531
      Vaccinated Population Contribution541
      Vaccination Coverage551
      Number of Doses per Person551
      Number of Total Doses551
      Doses Contribution561
      Number of Public and Private Doses571
    Cost of Vaccine571
    Total Revenue582
    Major Players by Market Share601
  Hong Kong611
    Vaccination Pattern611
      Population611
      Vaccinated Population Contribution621
      Vaccination Coverage631
      Number of Doses per Person631
      Number of Total Doses631
      Doses Contribution641
      Number of Doses Public and Private651
    Cost of Vaccine651
    Total Revenue662
    Major Players by Market Share681
  Singapore691
    Vaccination Pattern691
      Population691
      Vaccinated Population Contribution701
      Vaccination Coverage711
      Number of Doses per Person711
      Number of Total Doses711
      Doses Contribution721
      Number of Doses Public and Private731
    Cost of Vaccine731
    Total Revenue742
    Major Players by Market Share761
  Japan771
    Vaccination Pattern771
      Population771
      Vaccinated Population Contribution781
      Vaccination Coverage791
      Number of Doses per Person791
      Number of Total Doses792
    Cost of Vaccine811
    Total Revenue821
    Major Players in the Market831
  China841
    Vaccination Pattern841
      Population841
      Vaccinated Population Contribution851
      Vaccination Coverage861
      Number of Doses per Person861
      Number of Total Doses862
      Doses Contribution881
    Cost of Vaccine881
    Total Revenue892
    Major Players in the Market911
  India921
    Vaccination Pattern921
      Population921
      Vaccinated Population Contribution931
      Vaccination Coverage941
      Number of Doses per Person941
      Number of Total Doses942
      Doses Contribution961
    Cost of Vaccine961
    Total Revenue972
    Major Players in the Market991
Seasonal Influenza Vaccine Market in Asia-Pacific Region - Drivers and Restraints10012
  Drivers for the Seasonal Influenza Vaccine Market in the Asia-Pacific Region1001
    Threat of Pandemic Influenza1001
    Increasing Vaccination Coverage for Seasonal Influenza Vaccines1013
    Emergence of Novel Production Technologies and Vaccines1041
    Population Growth1051
    Economic Reasons1051
  Restraints for the Seasonal Influenza Vaccine Market in the Asia-Pacific Region1051
    Entry Barriers in the Seasonal Influenza Vaccine Market1051
    Variable Demand1061
    Limited Production Capacity1061
  Australia1061
    Drivers1061
      Government Support for Immunization against Seasonal Influenza1061
    Restraints1061
      Keeping Seasonal Influenza Vaccines Out of PBS1061
      Incidences of Adverse Reaction after Vaccination1061
  New Zealand1071
    Drivers1071
      Increasing Vaccination Coverage1071
      Government Support for Immunization1071
      Low Price for the Vaccine1071
    Restraints1071
      Low Vaccination Coverage for Influenza in Children1071
  Taiwan1071
    Drivers1071
      Growth in Elderly Population1071
      Government Support for Immunization1071
      Low Price of Vaccine1071
    Restraints1071
      Stagnating Vaccination Coverage1071
  Philippines1081
    Drivers1081
      Population Growth1081
      Rapid Increase in Vaccination Coverage1081
    Restraints1081
      Low Contribution from the Government1081
      High Price of Vaccine1081
  Malaysia1081
    Drivers1081
      Rapidly Increasing Vaccination Coverage1081
    Restraints1081
      Low Contribution from the Government1081
      Low Overall Coverage1081
      High Price of Vaccine1091
  Hong Kong1091
    Drivers1091
      Low Price of Seasonal Influenza Vaccine1091
      Government Programs for Seasonal Influenza Vaccination1091
      Rise in the Cost of Vaccine1091
    Restraints1091
      Low Contribution from the Government1091
  Singapore1091
    Drivers1091
      Rapidly Increasing Vaccination Coverage1091
      Increase in Elderly Population1101
    Restraints1101
      Low Contribution from the Government1101
  Japan1101
    Drivers1101
      Influenza Immunization Program1101
      Incidences of Pandemic Influenza1101
      Rapidly Growing Elderly Population1101
      Subsidized Immunization for the Elderly1101
    Restraints1101
      Non-reimbursement of Influenza Vaccination Costs1101
      Limited Availability Period for Subsidized Vaccines1101
      Absence of Scientific Studies Establishing Safety and Efficacy of Flu Vaccines in Japan1101
      Differential Pricing Among Prefectures1111
  China1111
    Drivers1111
      High Awareness about Flu Due to Pandemic Influenza1111
      Availability of Low-cost Flu Vaccines in China1111
    Restraints1111
      Absence of a National Influenza Vaccination Program1111
      Lack of Manufacturing Capacity1111
      Absence of Reimbursement on Seasonal Influenza Vaccination1111
  India1111
    Drivers1111
      Increasing Awareness about Seasonal Influenza1111
      Positive Prospects of Availability of a Low-cost Vaccine in Future1111
    Restraints1111
      Low Vaccination Coverage for Seasonal Influenza1111
      Absence of a National Influenza Vaccination Program1111
      Absence of Low-cost Domestic Manufacturers of Seasonal influenza Vaccines in India1111
Seasonal Influenza Vaccine Market in Asia-Pacific Region - Regulatory Landscape11218
  Registration Process and Regulations in Australia1122
  Registration Process and Regulations in New Zealand1143
  Registration Process and Regulations in Taiwan1171
  Registration Process and Regulations in the Philippines1182
  Registration Process and Regulations in Malaysia1202
  Registration Process and Regulations in Hong Kong1221
  Registration Process and Regulations in Singapore1231
  Registration Process and Regulations in Japan1242
  Registration Process and Regulations in China1262
  Registration Process and Regulations in India1282
Seasonal Influenza Vaccine Market in Asia-Pacific Region - Pipeline Analysis1308
  Seasonal Influenza Vaccines - Promising Vaccines under Clinical Development1301
  Profiles for Promising Vaccines under Clinical Development1311
    Optaflu1311
      Overview1311
      Efficacy1311
      Safety1311
      Clinical Study Details1311
    GSK2186877A1311
      Overview1311
      Efficacy1311
      Safety1321
      Clinical Study Details1321
    Intanza / Flu-ID1321
      Overview1321
      Efficacy1321
      Safety1321
      Clinical Study Details1321
    Fluad Pediatric1331
      Overview1331
      Efficacy1331
      Safety1331
      Clinical Study Details1331
    FluBlok1331
      Overview1331
  Research and Development Pipeline1344
Seasonal Influenza Vaccine Market in Asia-Pacific Region - Competitive Landscape1384
  Major Seasonal Influenza Vaccines Marketed in the APAC Region1381

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Seasonal Influenza Vaccine Market in Asia-Pacific Region - Cell Culture Technology-Based Vaccines to Revolutionize the Market by Faster Production and High Initial Purity" Dec 14, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Seasonal-Influenza-Vaccine-Market-in-Asia-Pacific-Region-Cell-Culture-Technology-Based-Vaccines-to-Revolutionize-the-Market-by-Faster-Production-and-High-Initial-Purity-2115-308>
  
APA:
GBI Research Reports. (2011). Seasonal Influenza Vaccine Market in Asia-Pacific Region - Cell Culture Technology-Based Vaccines to Revolutionize the Market by Faster Production and High Initial Purity Dec 14, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Seasonal-Influenza-Vaccine-Market-in-Asia-Pacific-Region-Cell-Culture-Technology-Based-Vaccines-to-Revolutionize-the-Market-by-Faster-Production-and-High-Initial-Purity-2115-308>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.